Viewing Study NCT00493311



Ignite Creation Date: 2024-05-05 @ 6:31 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00493311
Status: COMPLETED
Last Update Posted: 2016-10-19
First Post: 2007-06-27

Brief Title: Safety of Intravenous Acetaminophen Vs Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males
Sponsor: Mallinckrodt
Organization: Mallinckrodt

Study Overview

Official Title: A Phase III Randomized Double-Blind Placebo-Controlled Single-Dose Study of the Efficacy and Safety of Intravenous Acetaminophen Versus Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males
Status: COMPLETED
Status Verified Date: 2016-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A research study to determine if acetaminophen APAP given intravenously IV-a liquid given through a needle into a vein in your arm is safe and effective in controlling fever when compared to placebo Acetaminophen given this way is the investigational part of this study
Detailed Description: A Phase III Randomized Double-Blind Placebo-Controlled Single-Dose Study of the Efficacy and Safety of Intravenous Acetaminophen IVAPAP Versus Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None